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Hepatocyte-Specific β-Catenin Deletion 
During Severe Liver Injury Provokes 
Cholangiocytes to Differentiate Into 
Hepatocytes
Jacquelyn O. Russell,1,2 Wei-Yu Lu,3,7 Hirohisa Okabe,4,5 Marc Abrams,6 Michael Oertel,1,2 Minakshi Poddar,1,2 Sucha Singh,1,2 
Stuart J. Forbes,3 and Satdarshan P. Monga1,2,4,5
Liver regeneration after injury is normally mediated by proliferation of hepatocytes, although recent studies have 
suggested biliary epithelial cells (BECs) can differentiate into hepatocytes during severe liver injury when hepatocyte 
proliferation is impaired. We investigated the effect of hepatocyte-specific β-catenin deletion in recovery from severe 
liver injury and BEC-to-hepatocyte differentiation. To induce liver injury, we administered choline-deficient, ethio-
nine-supplemented (CDE) diet to three different mouse models, the first being mice with deletion of β-catenin in 
both BECs and hepatocytes (Albumin-Cre; Ctnnb1 flox/flox mice). In our second model, we performed hepatocyte line-
age tracing by injecting Ctnnb1 flox/flox; Rosa-stop flox/flox-EYFP mice with the adeno-associated virus serotype 8 encod-
ing Cre recombinase under the control of the thyroid binding globulin promoter, a virus that infects only hepatocytes. 
Finally, we performed BEC lineage tracing via Krt19-CreERT; Rosa-stop flox/flox-tdTomato mice. To observe BEC-to-
hepatocyte differentiation, mice were allowed to recover on normal diet following CDE diet–induced liver injury. 
Livers were collected from all mice and analyzed by quantitative real-time polymerase chain reaction, western blot-
ting, immunohistochemistry, and immunofluorescence. We show that mice with lack of β-catenin in hepatocytes 
placed on the CDE diet develop severe liver injury with impaired hepatocyte proliferation, creating a stimulus for 
BECs to differentiate into hepatocytes. In particular, we use both hepatocyte and BEC lineage tracing to show that 
BECs differentiate into hepatocytes, which go on to repopulate the liver during long-term recovery. Conclusion: 
β-catenin is important for liver regeneration after CDE diet–induced liver injury, and BEC-derived hepatocytes can 
permanently incorporate into the liver parenchyma to mediate liver regeneration. (Hepatology 2019;69:742-759).
SEE EDITORIAL ON PAGE 480
Despite the liver’s capacity for regenera-tion, chronic liver disease and cirrhosis is the twelfth leading cause of death in the 
United States.(1) This significant morbidity is attrib-
utable to lack of treatments for advanced liver dis-
ease besides liver transplantation, for which there is 
a severe shortage of donor organs.(2) Often, hepato-
cytes and biliary epithelial cells (BECs) can replicate 
Abbreviations: AAV8-TBG-Cre, adeno-associated virus serotype 8 encoding Cre recombinase under the hepatocyte-specific thyroid binding globulin 
promoter; ALP, alkaline phosphatase; ALT, alanine aminotransferase; ANOVA, analysis of variance; AST, aspartate aminotransferase; BECs, biliary 
epithelial cells; CDE, choline-deficient, ethionine-supplemented; EpCAM, epithelial cell adhesion molecule; EYFP, enhanced yellow fluorescence 
protein; GS, glutamine synthetase; IHC, immunohistochemistry; KO, knockout; LR, liver regeneration; PBS, phosphate-buffered saline; WT, wild-type.
Received July 12, 2018; accepted August 14, 2018.
Additional Supporting Information may be found at onlinelibrary.wiley.com/doi/10.1002/hep.30270/suppinfo.
Supported by NIH grants 1R01DK62277, 1R01DK100287, 1R01DK116993, and R01CA204586 and Endowed Chair for Experimental 
Pathology to S.P.M. This work was also supported by T32EB0010216 and 1F31DK115017-01 to J.O.R. In addition, S.J.F. and W.Y.L. are funded 
in part by MRC (Medical Research Council). We also thank Dr. Donghun Shin at the University of Pittsburgh for the use of his confocal microscope.
© 2018 The Authors. Hepatology published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases. This 
is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any 
medium, provided the original work is properly cited.
View this article online at wileyonlinelibrary.com.
DOI 10.1002/hep.30270
Potential conflict of interest: Dr. Abrams owns stock in Dicerna Pharmaceuticals.
Hepatology, Vol. 69, No. 2, 2019 Russell et al.
743
to replenish their respective cell types and eventually 
restore hepatic mass following injury. However, livers 
of patients with chronic liver disease exhibit ductular 
reaction,(3-5) with the degree of BEC expansion cor-
relating with disease severity.(6,7) The role of ductular 
reaction in liver regeneration (LR) remains contro-
versial, although studies are beginning to show BECs 
may be giving rise to hepatocytes. Indeed, experi-
mentally, when endogenous hepatocyte proliferation 
is impaired, reactive BECs(8,9) can differentiate into 
hepatocytes to mediate repair.(10,11) Alternatively, 
hepatocytes can differentiate into BECs, which can 
then be incorporated into biliary ductules(12,13) and 
may revert back to hepatocytes when injury is with-
drawn.(14) There is evidence of BEC-to-hepatocyte 
differentiation in both humans(15,16) and animal mod-
els of liver injury where hepatocyte proliferation is 
blocked(17-19) or after near total loss of hepatocytes.(20)
The choline-deficient, ethionine-supplemented 
(CDE) diet is a well-known liver injury diet that 
induces proliferation of reactive BECs.(21,22) Recent 
lineage tracing studies have demonstrated limited 
contribution of BECs to hepatocytes in CDE diet–
fed mice,(23-25) leading to the conclusion that BECs 
do not contribute significantly to the restoration of 
hepatocyte mass after chronic liver injury. However, 
the CDE diet does not block hepatocyte prolifer-
ation(25) and thus is unable to provide the correct 
milieu for BEC-to-hepatocyte transdifferentiation. 
Because the Wnt/β-catenin signaling pathway is 
a major driver of hepatocyte proliferation during 
LR,(26,27) we investigated if CDE diet–induced injury 
to conditional β-catenin knockout mice will neces-
sitate BEC-mediated liver repair. We used multi-
ple mouse models to perform hepatocyte and BEC 
lineage tracing in mice that underwent modulation 
of β-catenin expression and were administered CDE 
diet. Our results demonstrate that loss of β-catenin 
in hepatocytes during CDE diet–induced liver injury 
indeed impairs hepatocyte proliferation, triggering the 
expansion of BECs, which subsequently differentiate 
into hepatocytes. We have successfully established a 
model that will lend itself well to the study of the 
mechanisms of BEC expansion and differentiation.
Materials and Methods
Mouse stRaINs, VIRal 
INFeCtIoNs, taMoXIFeN 
aDMINIstRatIoN, IN VIVO RNaI, 
aND DIet
All animals are housed in temperature- and 
light-controlled facilities and are maintained in 
accordance with the Guide for Care and Use of 
Laboratory Animals and the Animal Welfare Act. 
Albumin-Cre;Ctnnb1  flox/flox mice or knockout (KO) 
1 and wild-type (WT) 1 littermate controls(28) were 
maintained on a C57BL/6 background. Ctnnb1  flox/flox; 
Rosa-stop  flox/flox-EYFP reporter mice were gener-
ated through breeding Ctnnb1  flox/flox mice with 
 Rosa-stop  flox/flox-EYFP mice ( Jackson Laboratories). 
Krt19-CreERT; Rosa-stop  flox/flox-tdTomato reporter mice 
were described previously.(17) To label hepatocytes and 
generate KO2 mice, 23-25-day-old Ctnnb1  flox/flox; 
Rosa-stop  flox/flox-EYFP mice were injected intraperi-
toneally with 1×1012 genome copies of adeno-associ-
ated virus  serotype 8 encoding Cre recombinase under 
the hepatocyte-specific thyroid binding globulin 
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Edinburgh, Edinburgh, UK; 4 Department of Medicine,  University of Pittsburgh School of Medicine and University of Pittsburgh 
Medical Center, Pittsburgh, PA; 5 Department of Gastroenterological Surgery,  Kumamoto University, Kumamoto, Japan; 6 Dicerna 
Pharmaceuticals, Boston, MA; 7 Centre for Liver Research,  University of Birmingham, Birmingham, UK.
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promoter (AAV8-TBG-Cre) (Penn Vector Core) fol-
lowed by a 12-day washout period. To generate WT2 
mice, the same AAV8-TBG-Cre was injected into or 
Ctnnb1+/+;Rosa-stop  flox/flox-EYFP mice. To label BECs, 
Krt19-CreERT; Rosa-stop  flox/flox-tdTomato mice were 
given 3 doses of 12.5 mg/kg tamoxifen during post-
natal week 1, followed by 2 weeks of washout. For the 
liver injury time point, 4-5-week-old mice were given 
choline-deficient diet (Envigo Teklad Diets) supple-
mented with 0.15% ethionine drinking water (Acros 
Organics, 146170100) for 2-3 weeks (Krt19-CreERT; 
Rosa-stop  flox/flox-tdTomato mice). For recovery time 
points, animals were switched back to normal chow 
diet for 3 days up to 6 months after 2 weeks of CDE 
diet. For in vivo knockdown of β-catenin expression, 
both C57BL6/NJ (Charles River) and Krt19-CreERT; 
Rosa-stop  flox/flox-tdTomato mice were given biweekly or 
weekly subcutaneous injections of 5 mg/kg Ctnnb1-
siRNA dissolved in phosphate-buffered saline 
(PBS) or PBS as a control starting 1 week prior to 
CDE diet administration and continuing throughout 
CDE diet and recovery periods. The small interfer-
ing RNA (siRNA) (Dicerna Pharmaceuticals) was 
conjugated to N-acetylgalactosamine, which allows 
hepatocyte-specific knockdown of target gene expres-
sion.(29) Serum biochemistry analysis was performed 
by automated methods at the University of Pittsburgh 
Medical Center clinical chemistry laboratory. All 
studies were performed according to the guidelines of 
the National Institutes of Health and the University 
of Pittsburgh Institutional Animal Use and Care 
Committee.
IMMuNoHIstoCHeMIstRy
See Supporting Methods.
IMMuNoFluoResCeNCe
See Supporting Methods.
Cell QuaNtIFICatIoN
In the negative lineage tracing model, samples were 
triple stained for β-catenin, enhanced yellow fluores-
cence protein (EYFP), and Hnf4α as described above. 
For each sample, eight images at ×200 magnification 
of periportal regions were taken and in each image the 
number of EYFP+/Hnf4α+ and EYFP-/Hnf4α+ cells 
were counted. A minimum of 700 cells were counted 
for every sample. In the positive lineage tracing 
model, images were obtained on a Zeiss Axiovert 200 
microscope using a Zeiss Axiocam MR camera. Cell 
counts were performed manually on blinded slides 
and more than 20 consecutive fields at ×200 magnifi-
cation. Hepatocytes and cholangiocytes were defined 
as Hnf4α and CK19 positive cells, respectively. Cells 
were counted with ImageJ cell counter program.
WesteRN BlottINg
See Supporting Methods.
Rt-pCR
See Supporting Methods.
statIstICs
For analysis of serum biochemistry between two 
groups, a two-tailed t test was performed. For anal-
ysis of gene expression data between more than two 
groups, a one-way analysis of variance (ANOVA) was 
performed. For analysis of cell counts, such as prolif-
erating hepatocytes, a Mann-Whitney U test was per-
formed. For analysis of change in body weight over 
time, a two-way ANOVA was performed. A P < 0.05 
was considered significant, and plots are mean ± SD. 
All statistical analysis and graph generation was per-
formed using GraphPad Prism 7 software.
Results
β-CateNIN Is IMpoRtaNt FoR 
lR aFteR CDe DIet–INDuCeD 
lIVeR INJuRy
To test whether lack of β-catenin in hepatocytes 
impairs hepatocyte proliferation in a chronic liver injury 
setting, we placed KO1 mice(28) lacking β-catenin 
in hepatocytes and BECs, and WT1 mice on CDE diet 
for 2 weeks (Fig. 1A). KO1 showed severe  histological 
abnormalities including steatohepatitis (Fig. 1F), with 
gross liver morphology displaying pale and smller 
livers (Fig. 1B). Serum liver injury markers, alanine 
aminotransferase (ALT) (Fig. 1C), serum aspar-
tate aminotransferase (AST) (Supporting Fig. S1D), 
and bilirubin (Fig. 1D) were significantly elevated in 
KO1 compared with WT1 on CDE diet. There was 
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FIg. 1. KO1 mice display severe liver injury and impaired hepatocyte proliferation after CDE diet. (A) Four-week-old male WT1 
and KO1 mice were placed on CDE diet for 2W to induce liver injury. (B) Gross liver morphology reveals small and pale livers in KO1 
mice after 2W of CDE diet. (C) Serum liver injury marker ALT is significantly elevated in KO1 mice after CDE diet compared with 
both WT1 mice and baseline ND levels (t test, ** = P < 0.01). (D) Serum bilirubin is significantly elevated in KO1 mice after CDE 
diet compared with both WT1 mice and baseline ND levels (t test, **** = P < 0.0001). (E) Quantification of hepatocyte proliferation in 
mice after 2W of CDE diet reveals significantly impaired hepatocyte proliferation in KO1 mice (Mann-Whitney U test, ** = P < 0.01). 
(F) KO1 mice display prominent steatohepatitis and few Ki67 or Cyclin D1-positive hepatocytes (scale bar 50 µm). (G) Hepatic Ccnd1 
gene expression is upregulated after 2W of CDE diet, but is impaired in KO1 mice (one-way ANOVA, * = P < 0.05). (H) Whole liver 
lysates display dramatically reduced levels of β-catenin and active β-catenin in KO1 mice, whereas WT1 animals exhibit upregulation 
of both proteins after CDE diet. Abbreviations: ND, normal diet; W, weeks.
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no difference in serum alkaline phosphatase (ALP) 
levels in WT1 and KO1 mice (Supporting Fig. S1E). 
Both WT1 and KO1 displayed characteristic expan-
sion of reactive BECs, which are positive for BEC-
marker CK19 (Supporting Fig. S1A), although KO1 
displayed a more robust BEC expansion as deter-
mined by increased expression of BEC markers Krt19 
and Sox9 (Supporting Fig. S1F,G). KO1 also displayed 
increased fibrosis by Sirius Red staining (Supporting 
Fig. S1A) and increased expression of profibrotic genes 
Col1a1 (Supporting Fig. S1B) and Acta2 (Supporting 
Fig. S1C,H). We detected increased cell death as 
evidenced by terminal deoxynucleotidyl transferase–
mediated deoxyuridine triphosphate nick-end labeling 
staining (Supporting Fig. S1A) and increased hepato-
cyte senescence in KO1 as evidenced by an increase in 
p21-positive hepatocytes (Supporting Fig. S1A) and 
increased levels of p21 protein (Supporting Fig. S1H) 
compared with WT1. Collectively, we detect severe 
liver injury in KO1 mice on CDE diet.
To determine if there was a defect in LR in KO1, we 
assessed hepatocyte proliferation via Ki67 and Cyclin 
D1 immunohistochemistry (IHC) (Fig. 1F). Whereas 
WT1 displayed robust hepatocyte proliferation and 
Cyclin D1 expression especially in periportal hepato-
cytes, KO1 displayed significantly impaired hepatocyte 
proliferation (Fig. 1E) and reduced Ccnd1 expres-
sion (Fig. 1G) and protein (Supporting Fig. S1H). 
As expected, low levels of β-catenin protein were 
observed in KO1 livers, likely due to nonparenchy-
mal cells (Fig. 1H). However, there was no expression 
of active-β-catenin (hypophosphorylated) in KO1 
mice even after CDE diet (Fig. 1H). Alternatively, 
there was increased total and active-β-catenin levels 
in WT1 mice on CDE diet compared with normal 
diet (Fig. 1H). This suggests activation of β-catenin 
signaling is contributing to hepatocyte proliferation, 
and deletion of β-catenin leads to impaired hepato-
cyte proliferation and defective LR after CDE diet.
laCK oF β-CateNIN IN 
HepatoCytes IMpaIRs 
HepatoCyte pRolIFeRatIoN 
aND pRoMotes INJuRy FRoM 
tHe CDe DIet
As KO1 mice on CDE diet displayed severe 
liver injury, impaired hepatocyte proliferation, and 
robust expansion of BECs, we hypothesized BEC 
differentiation to hepatocytes would be activated to 
mediate restoration of hepatocyte mass. To test this 
hypothesis, we generated KO2 mice.(23) Genes in 
the Rosa locus are ubiquitously expressed, but prior 
to Cre recombination, a floxed stop codon inacti-
vates expression of the Rosa-driven EYFP reporter 
gene.(30) AAV8 infects only hepatocytes, and greater 
than 99% of hepatocytes can be permanently labeled 
with EYFP after AAV8-TBG-Cre injection.(23,25,31) 
We administered a single injection of AAV8-TBG-
Cre and allowed 12-day washout before administering 
CDE diet (Fig. 2A) to allow for clearance of residual 
viral genome.(32) In KO2, hepatocytes lack β-catenin 
expression and are permanently labeled with EYFP 
(Fig. 2B). Importantly, BECs are not infected with 
AAV8 and thus retain β-catenin and do not express 
EYFP. Therefore, hepatocytes originating from BECs 
will be negative for EYFP and express β-catenin 
(Fig. 2F). As controls, WT2 mice showed EYFP-
labeled hepatocytes that retain β-catenin expression. 
IHC confirmed β-catenin expression in hepatocytes 
in WT2 mice but not in KO2 mice (Supporting 
Fig. S2A).
KO2 on CDE diet, like KO1, showed severe liver 
injury reflected by significantly increased serum AST 
(Fig. 2C), serum ALT (Supporting Fig. S2D), and bil-
irubin levels (Fig. 2D) as compared with WT2. WT2 
mice on CDE diet initially lost weight but began to 
recover after 5-7 days. In contrast, KO2 mice con-
tinued to lose weight over the course of CDE diet 
administration (Fig. 2E), suggesting failure to recover 
from injury. Both WT2 and KO2 mice displayed 
expansion of BECs (Fig. S2A), confirmed by increased 
Krt19 (Supporting Fig. S2F) and Sox9 (Supporting 
Fig. S2G) expression. KO2 and WT2 mice devel-
oped fibrosis after 2 weeks of CDE diet, evident by 
increased Sirius Red staining (Supporting Fig. S2A) 
and increased expression of Col1a1 (Supporting 
Fig. S2B) and Acta2 (Supporting Fig. S2C). KO2 
mice on CDE diet also displayed increased p21-pos-
itive hepatocytes (Supporting Fig. S2A) and overall 
p21 protein levels (Supporting Fig. S2H).
When hepatocyte proliferation was assessed by 
Ki67 staining, WT2 mice also displayed robust peri-
portal hepatocyte proliferation, which was nearly 
absent in KO2 mice (Fig. 2G,H). WT2 mice, like 
WT1, displayed increased Ccnd1 gene (Fig. 2I) and 
protein expression (Supporting Fig. S2H) after CDE 
diet, which was significantly abrogated in KO2. This 
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FIg. 2. KO2 mice display severe liver injury and impaired hepatocyte proliferation after CDE diet–induced liver injury. (A) Male 
24-25-day-old Ctnnb1flox/flox; Rosa-stopflox/flox-EYFP or Ctnnb1+/+; Rosa-stopflox/flox-EYFP mice were injected with AAV8-TBG-Cre to 
generate KO2 and WT2 mice, respectively, followed by 12 days of wash-out on normal diet before 2 weeks of CDE diet. (B) Schematic 
of cell labeling after AAV8-TBG-Cre injection, only hepatocytes (maroon hexagons) will be labeled with EYFP and will lose β-catenin 
expression (black outline). BECs (green circles) will not be altered by AAV8-TBG-Cre injection. (C) Serum liver injury marker AST is 
significantly elevated in KO2 mice after CDE diet compared with WT2 mice (t test, **** = P < 0.0001). (D) Serum bilirubin is significantly 
elevated in KO2 mice after CDE diet compared with WT2 mice (t test, **** = P < 0.0001). (E) KO2 mice lose significantly more body 
weight compared with WT2 mice after CDE diet (WT2 n = 22, KO2 n =11, two-way ANOVA, **** = P < 0.0001). (F) Schematic of fate 
tracing showing that any BECs that give rise to hepatocytes will be negative for EYFP and will express β-catenin. (G) IHC shows many 
Ki67-positive hepatocytes in WT2 mice but not in KO2 after CDE diet (scale bar 50 µm). (H) Quantification reveals fewer Ki67-positive 
hepatocytes in KO2 mice after CDE diet (Mann-Whitney U test, ** = P < 0.01). (I) Hepatic Ccnd1 gene expression is significantly elevated 
in WT2 mice after CDE diet, but impaired in KO2 mice (one-way ANOVA, ** = P < 0.01). ( J) No BEC-derived hepatocytes (EYFP 
negative, β-catenin positive) were evident in either WT2 or KO2 mice after 2 weeks of CDE diet (scale bar 50 µm).
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suggests severely impaired hepatocyte proliferation in 
KO2 mice after 2 weeks of CDE diet. We did not 
detect any β-catenin-positive, EYFP-negative hepato-
cytes in KO2 (Fig. 2J), suggesting no BEC-derived 
hepatocytes (Fig. 2F) were present at this time. 
Corroborating this observation, we did not detect an 
increase in total β-catenin levels in KO2 mice after 
2 weeks of CDE diet in comparison with KO2 mice 
left on normal diet. However, we did detect active 
β-catenin in KO2 mice on CDE diet, which was 
absent in KO2 mice on normal diet (Supporting Fig. 
S2H). This suggests active-β-catenin is present in 
β-catenin-positive BEC compartment, and that BEC 
differentiation into hepatocytes had yet to occur.
DeFeCtIVe HepatoCyte 
pRolIFeRatIoN IN Ko2 MICe 
DRIVes BeC-to-HepatoCyte 
DIFFeReNtIatIoN aFteR CDe 
DIet-INDuCeD HepatIC INJuRy
To facilitate BEC-driven repair, we next admin-
istered CDE diet to WT2 and KO2 mice for 
2 weeks, followed by recovery on normal diet for 
2 weeks(17,19,33) (Fig. 3A). Both WT2 and KO2 dis-
played normal serum ALT (Fig. 3C), although KO2 
displayed slightly elevated serum bilirubin (Fig. 3D) 
and ALP (Fig. 3E) compared with WT2. Excitingly, in 
KO2 mice we detected clusters of β-catenin-positive, 
EYFP-negative cells, which stained positively for 
hepatocyte marker Hnf4α (Fig. 3G), indicating 
BEC-derived hepatocytes (Fig. 3B). We did not 
detect expansion of EYFP-negative hepatocytes in 
WT2 mice, suggesting that BECs do not give rise 
to hepatocytes in animals when hepatocyte prolif-
eration is not impaired, consistent with previous 
reports.(14,23,25) An alternative explanation for these 
cells is that they were hepatocytes that escaped ini-
tial Cre recombination, which could result in EYFP-
negative, β-catenin-positive hepatocytes. However, 
we would predict the efficiency of AAV8-TBG-
Cre to be the same in both WT2 and KO2 mice. 
Therefore, we quantified the number of EYFP-
positive/negative hepatocytes in our WT2 and KO2 
mice over the course of CDE diet injury and recov-
ery (Fig. 3F). First, we quantified the number of 
EYFP-positive hepatocytes in WT2 and KO2 mice 
12 days after injection with AAV8-TBG-Cre, cor-
responding to the initial labeling efficiency before 
the onset of liver injury. We found that greater than 
99% of hepatocytes were EYFP positive, consistent 
with previous reports.(23,25) After 2 weeks of CDE 
diet, the percentage of EYFP-negative hepatocytes 
was not significantly increased in either WT2 or 
KO2. However, after 2 weeks of recovery after CDE 
diet–induced liver injury, in KO2 mice approxi-
mately 20% of periportal hepatocytes were EYFP 
negative, whereas the percentage of EYFP-negative 
hepatocytes in WT2 mice did not increase (Fig. 3F).
Correspondingly, tiled images (and serial high-
er-magnification images from a representative area) 
from KO2 mice of representative lobes stained for 
β-catenin revealed no clusters of β-catenin-positive 
hepatocytes after 2 weeks of CDE diet (Supporting 
Fig. S3A,B), whereas after 2 weeks of CDE diet 
followed by 2 weeks of recovery on normal diet, 
many clusters of β-catenin-positive hepatocytes 
were evident across the entire lobe (and serial high-
er-magnification images from a representative area) 
(Supporting Fig. S3C,D). Likewise, hepatic Ctnnb1 
expression tended to increase in KO2 mice after 
CDE diet and recovery, although it was still signifi-
cantly lower than WT2 mice. In age-matched control 
mice left on normal diet for 6 weeks after AAV8-
TBG-Cre injection, hepatic gene expression of 
Ctnnb1 was greatly reduced in KO2 mice compared 
with WT2 mice (Supporting Fig. S3E), indicating 
lack of repopulation of  β-catenin-positive hepato-
cytes in the absence of liver injury. These results, in 
combination with lack of expansion of EYFP-
negative hepatocytes in WT2 after CDE diet injury 
and recovery, support BEC-to-hepatocyte conver-
sion in KO2 over expansion of Cre-recombinase 
escaped cells.
BeC-DeRIVeD β-CateNIN-
posItIVe HepatoCytes aRe 
MoRe pRolIFeRatIVe tHaN 
eNDogeNous HepatoCytes
Analysis of hepatic sections from KO2 mice after 
2 weeks of recovery on normal chow following 2 weeks 
of CDE diet showed that nearly all  β-catenin-positive 
hepatocytes were located in clusters adjacent to 
BECs in the periportal region (Supporting Fig. S3B). 
This may also explain the lack of reappearance 
of pericentral β-catenin target glutamine synthe-
tase (GS)(26,34) in KO2 mice at this time (Fig. 4C). 
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The reactive BEC response was extensive after 
2 weeks of CDE diet and recovery, as evidenced by 
large numbers of epithelial cell adhesion molecule 
(EpCAM)–positive BECs (Supporting Fig. S4A). The 
extent of BEC expansion was similar in WT2 and 
KO2, as indicated by comparable hepatic expression 
FIg. 3. BEC-derived hepatocytes appear in KO2 but not WT2 mice following recovery after CDE diet. (A) Male 24-25-day-old 
Ctnnb1flox/flox; Rosa-stopflox/flox-EYFP or Ctnnb1+/+; Rosa-stopflox/flox-EYFP mice were injected with AAV8-TBG-Cre to generate KO2 
and WT2 mice, respectively, followed by 12 days of wash-out on normal diet before 2W of CDE diet followed by another 2W of recovery 
on normal chow. (B) Schematic of fate tracing depicting BECs that give rise to hepatocytes will be negative for EYFP and will express 
β-catenin. (C) Serum ALT levels normalize after 2W of recovery post-CDE diet in both WT2 and KO2 mice. (D) Serum bilirubin 
levels are reduced in KO2 mice compared with immediate post-CDE-diet injury levels but are still significantly elevated in comparison 
with WT2 mice following 2W of recovery (t test, ** = P < 0.01). (E) Serum ALP levels are significantly elevated in KO2 compared 
with WT2 mice after CDE 2W and 2W of recovery (t test, *** = P < 0.001). (F) Over 99% of hepatocytes are EYFP positive in WT2 
and KO2 mice both prior to injury (ND 12 days) and after 2W of CDE diet–induced liver injury (CDE 2W). After recovery on normal 
diet following CDE diet, approximately 20% of periportal hepatocytes are EYFP negative in KO2 mice, whereas there is no reduction 
in EYFP-positive hepatocytes in WT2 mice. (G) Hnf4α-positive hepatocytes that are negative for EYFP and positive for β-catenin 
appear in KO2 mice after CDE diet and recovery. No EYFP-negative hepatocytes are apparent in WT2 mice (scale bar 50 µm). 
Abbreviations: ND, normal diet; W, weeks.
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FIg. 4. β-catenin-positive hepatocytes preferentially proliferate to restore lost hepatocyte mass. (A) The majority of BEC-derived 
β-catenin-positive hepatocytes in a given cluster are PCNA positive (scale bar 50 µm). (B) Quantification of PCNA reveals β-catenin-
positive hepatocytes are significantly more proliferative than surrounding β-catenin-negative hepatocytes (Mann-Whitney U test, 
** = P < 0.01). (C) There is an increase in total β-catenin, active β-catenin, and Cyclin D1 levels in KO2 mice after CDE diet and 
recovery compared with KO2 mice left on normal diet. Because all BEC-derived hepatocytes are located in the periportal region, 
there is no re-expression of pericentral β-catenin target GS. (D) IHC staining for β-catenin reveals no β-catenin-positive hepatocytes 
in KO2 mice after 2W on CDE diet with 0 days of recovery. However, a few β-catenin-positive hepatocytes are visible after 3 days of 
recovery (red arrow), with clusters of β-catenin-positive hepatocytes increasing in size from 7 to 14 days of recovery on normal diet 
(scale bar 50 µm). (E) β-catenin-positive cells that express both BEC marker CK19 and hepatocyte marker Hnf4α can be found in KO2 
mice after 2W on CDE diet followed by 7 days of recovery on normal diet (scale bar 10 µm). Abbreviations: ND, normal diet; PCNA, 
proliferating cell nuclear antigen; W, weeks.
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of BEC markers Krt19 (Supporting Fig. S4B) and 
Sox9 (Supporting Fig. S4C). There was ongoing 
fibrosis in both WT2 and KO2 as evidenced by Sirius 
Red staining even after 2 weeks of recovery on  normal 
diet (Supporting Fig. S4A), which is likely due to 
ongoing reactive BEC response, which is known to 
secrete profibrogenic cytokines.(35) This level of fibro-
sis also indicated that repair of CDE diet–induced 
liver injury was not complete after 2 weeks of recovery 
on normal diet.
To determine if BEC-derived, β-catenin-positive 
hepatocytes were driving restoration of hepatocyte 
mass in KO2 mice after CDE diet–induced liver 
injury, we performed triple immunofluorescence for 
Hnf4α, β-catenin, and proliferating cell nuclear anti-
gen (PCNA) (Fig. 4A). Within a given cluster of 
β-catenin-positive hepatocytes in KO2, the majority 
of β-catenin-positive hepatocytes stained positively 
for PCNA. Indeed, periportal β-catenin-positive 
hepatocytes were significantly more proliferative than 
surrounding β-catenin-negative hepatocytes in KO2 
(Fig. 4B). Likewise, clusters of periportal hepatocytes 
in KO2 were strongly Cyclin D1 positive in com-
parison with surrounding hepatocytes (Supporting 
Fig. S4A, red arrows). KO2 also displayed increased 
total Cyclin D1 protein compared with WT2 after 2 
weeks of CDE diet and recovery (Fig. 4C). There was 
also a noticeable increase in total and active-β-cat-
enin in KO2 after recovery in comparison with age-
matched KO2 left on normal diet for 6 weeks (Fig. 
4C), indicating repopulation by β-catenin-positive 
cells in KO2 during repair. Collectively, these results 
demonstrate BEC-derived β-catenin-positive hepato-
cytes are preferentially proliferating to replenish lost 
hepatic mass in KO2 mice.
BeC DIFFeReNtIatIoN to 
HepatoCytes oCCuRs eaRly IN 
ReCoVeRy oN NoRMal DIet
To determine if the BEC-derived hepatocytes after 
2 weeks of recovery on normal diet express BEC 
markers, we performed triple immunofluorescence 
with a wide-spectrum cytokeratin antibody (PanCK) 
in addition to EYFP and hepatocyte marker Hnf4α 
(Supporting Fig. S4D). EYFP-negative hepato-
cytes were PanCK negative (Supporting Fig. S4D, 
white arrowhead), and as expected the majority of 
cytokeratin-positive BECs were negative for EYFP. 
Interestingly, rare EYFP-positive BECs were observed 
in both WT2 and KO2 mice (Supporting Fig. S4D, 
white arrows), potentially indicating hepatocyte-to-
BEC transdifferentiation after CDE diet–induced 
liver injury. When we performed staining for a second 
BEC marker, EpCAM, we observed rare cells with 
hepatocyte-like morphology, which were EpCAM 
positive in KO2 mice (Supporting Fig. S4A, black 
arrows). This finding correlates with the observations 
of EpCAM-positive hepatocytes in human patients 
with BEC expansion after severe liver injury.(16) These 
results demonstrate that after 2 weeks of recovery on 
normal diet, the majority of BEC-derived hepatocytes 
in KO2 mice do not express BEC markers.
To further explore the timing of BEC-to-
hepatocyte differentiation during recovery from CDE 
diet, we harvested KO2 mice after 3 days or 7 days of 
recovery on normal diet post-CDE diet (Supporting 
Fig. S5A). Excitingly, very few small β-catenin- 
positive hepatocyte-like cells are evident after 3 
days of recovery, which grow into small clusters of 
β-catenin-positive cells with hepatocyte morphology 
after 7 days of recovery (Fig. 4D, red arrows). These 
clusters are even larger following 2 weeks of recovery 
on normal diet, suggesting potential clonal expan-
sion of BEC-derived, β-catenin-positive hepato-
cytes. Interestingly, serum ALT levels are dramatically 
reduced following 3 days of recovery on normal diet 
(Supporting Fig. S5B), whereas both serum bilirubin 
and ALP levels remain elevated after 3 days of recov-
ery and only begin to normalize after 7 or 14 days 
of recovery, respectively (Supporting Fig. S5C,D), 
potentially suggesting abatement of acute liver injury 
may be required for expansion of these cells. Similar 
serum liver injury profiles and appearance of small 
β-catenin-positive hepatocytes were also observed in 
female KO2 mice after CDE diet and 3 days of recov-
ery (data not shown), suggesting BEC-to-hepatocyte 
differentiation also occurs in female mice following 
recovery from CDE diet–induced liver injury.
We next investigated the expression of Hnf4α in 
these putative transdifferentiating BECs over time. 
After 2 weeks of CDE diet, virtually all β-catenin- 
positive cells were positive for CK19 and negative 
for Hnf4α (Supporting Fig. S5E). However, as early 
as after 3 days of recovery, we detected β-catenin- 
positive cells that were CK19 positive and weakly pos-
itive for Hnf4α (Supporting Fig. S5F). After 7 days of 
recovery on normal diet, rare β-catenin-positive cells 
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were observed, which were strongly positive for both 
CK19 and Hnf4α (Fig. 4E). At this time point, clusters 
containing β-catenin+/Hnf4α+/CK19− hepatocytes 
were evident (Supporting Fig. S5G). The rarity of 
the β-catenin+/Hnf4α+/CK19+ cells in  combination 
with the increased proliferation of β-catenin- 
positive hepatocytes suggests that few BECs differen-
tiate into hepatocytes, which subsequently proliferate 
to restore lost hepatocyte mass in KO2 mice.
BeC-DeRIVeD HepatoCytes 
Repopulate tHe lIVeR DuRINg 
loNg-teRM ReCoVeRy
Previous studies have demonstrated that transdif-
ferentiated cells, such as hepatocyte-derived BECs, 
may revert back to their original cell type when 
liver injury has abated.(14) Alternatively, it has been 
shown that with persistent need for transdifferen-
tiated cells, such as in mice that lack the intrahe-
patic biliary system, hepatocyte-to-BEC conversion 
is permanent and stable for life.(13) To determine if 
BEC-derived hepatocytes would persist and fur-
ther repopulate the liver, KO2 mice were allowed 
to recover on normal diet for either 3 or 6 months 
after CDE diet (Fig. 5A). As a control, we traced 
WT2 and KO2 mice for 6 months on normal diet to 
determine the persistence of EYFP labeling in the 
absence of injury. Serum ALT levels were normal 
in both WT2 and KO2 (Fig. 5B,C). Interestingly, 
KO2 mice left on normal diet for 6 months showed 
minor elevation of bilirubin compared with WT2 
(Fig. 5C). KO2 mice after long-term recovery from 
CDE diet showed extensive expansion of EYFP-
negative, β-catenin-positive hepatocytes (Fig. 5E), 
as evidenced by central veins that were partially 
or completely GS positive (Supporting Fig. S6A). 
When we quantified the number of EYFP-positive 
hepatocytes, we found that in control WT2 and 
KO2 left on normal diet for 6 months, there was 
no significant expansion of EYFP-negative hepato-
cytes, similar to WT2 after long-term recovery 
from CDE diet (Fig. 5D). However, in KO2 after 
3 months of recovery from CDE diet, up to 70% of 
hepatocytes were EYFP negative, and this number 
remained stable after 6 months of recovery. In con-
trol KO2 mice left on normal diet for 6 months, vir-
tually all EYFP-positive hepatocytes were β-catenin 
negative (Supporting Fig. S6B), as confirmed by 
β-catenin IHC (Supporting Fig. S6C). Hepatic 
expression of Ctnnb1 was significantly reduced in 
KO2 mice left on normal diet for 6 months com-
pared with control WT2 mice, whereas expression 
of Ctnnb1 in KO2 after recovery from CDE diet 
began to approach WT2 levels (Supporting Fig. 
S6D). The lack of expansion of EYFP-negative 
hepatocytes in WT2 mice even after 6 months of 
recovery post-CDE diet, combined with the lack of 
expansion of EYFP-negative hepatocytes in KO2 
left on normal diet, further supports our hypothesis 
that BEC-derived hepatocytes repopulate the liver 
in KO2 after CDE diet–induced liver injury.
IN VIVO Ctnnb1 RNaI IMpaIRs 
HepatoCyte pRolIFeRatIoN 
aFteR CDe DIet-INDuCeD 
lIVeR INJuRy
To prove BECs were indeed giving rise to hepato-
cytes in our model, we sought to perform direct lineage 
tracing of BECs using tamoxifen-inducible Krt19-Cre 
to label BECs with the reporter tdTomato. However, 
the use of Cre recombinase to label BECs precluded 
the use of Cre recombinase to delete Ctnnb1 specif-
ically in hepatocytes. To achieve labeling of BECs 
with a reporter and simultaneous knockdown of 
Ctnnb1 expression in hepatocytes, we used Ctnnb1-
siRNA conjugated to hepatocyte-targeting ligand 
N-acetylgalactosamine.(36) To validate that Ctnnb1-
siRNA injection would recapitulate the phenotype of 
CDE diet–fed mice with genetic hepatocyte-specific 
Ctnnb1 deletion, we performed weekly subcutaneous 
injections of Ctnnb1-siRNA in mice fed CDE diet. 
The first injection was performed 1 week before CDE 
diet exposure to ensure reduced β-catenin levels in 
hepatocytes at the time of CDE diet administration 
(Fig. 6A).
Real-time PCR analysis demonstrated significant 
reduction of hepatic Ctnnb1 gene expression in Ctnnb1-
siRNA-injected mice compared with PBS-injected 
control mice on CDE diet (Fig. 6B). Ctnnb1-siRNA-
injected mice fed CDE diet for 2 weeks displayed 
significantly elevated serum ALT (Fig. 6C), AST 
(Fig. 6D), and bilirubin levels (Fig. 6F) compared with 
control PBS-injected mice. We additionally confirmed 
reduction in both total and active β-catenin protein 
levels, as well as loss of expression of β-catenin down-
stream target GS, in Ctnnb1-siRNA-injected mice 
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FIg. 5. β-catenin-positive hepatocytes repopulate the majority of the liver during long-term recovery. (A) After CDE diet treatment, 
WT2 and KO2 mice were allowed to recover on normal diet for either 3 or 6 months. As a control, WT2 and KO2 mice that were never 
exposed to CDE diet were traced for 6 months after AAV8 injection. (B) Serum ALT levels are normal in both WT2 and KO2 mice 
after long-term recovery on normal diet. (C) Serum bilirubin levels are normal in both WT2 and KO2 mice on long-term recovery on 
normal diet, although serum bilirubin is slightly elevated in control KO2 mice kept on normal diet for 6 months (one-way ANOVA, 
* = P < 0.05). (D) There is no significant expansion of EYFP-negative hepatocytes in control WT2 and KO2 mice left on normal diet 
for 6 months (blue bars), or in WT2 mice exposed to CDE diet for 2W and allowed to recover on normal diet for up to 6 months. 
However, in KO2 mice, up to 70% of hepatocytes are EYFP negative after 6 months of recovery on normal diet following CDE 
diet–induced liver injury. (E) Expansion of EYFP-negative hepatocytes is only evident in KO2, not WT2, mice after 6 months of 
recovery on normal diet following CDE diet–induced liver injury. Abbreviations: mo, months; ND, normal diet; W, weeks.
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FIg. 6. Hepatocyte-specific in vivo Ctnnb1 siRNA induces severe liver injury and a block of hepatocyte proliferation in CDE diet–fed 
mice. (A) C57BL6/NJ mice were placed on CDE diet for 2 weeks. Mice were given weekly subcutaneous injections of Ctnnb1-siRNA 
dissolved in PBS or PBS control, 1 week prior to CDE diet administration and throughout the course of CDE diet feeding. (B) RT-PCR 
analysis of Ctnnb1 gene expression in whole liver lysates of Ctnnb1-siRNA or PBS-injected mice on CDE diet (t test, ** = P < 0.01). 
(C) Significantly elevated serum ALT levels in Ctnnb1-siRNA-injected mice compared with PBS controls (t test, ** = P < 0.01). 
(D) Significantly elevated serum AST levels in Ctnnb1-siRNA-injected mice compared with PBS controls (t test, ** = P < 0.01). (E) Whole 
liver lysate reveals reduction in total β-catenin and active β-catenin, as well as complete loss of β-catenin-target GS in Ctnnb1-siRNA-
injected mice on CDE diet. (F) Significantly elevated serum bilirubin levels in Ctnnb1-siRNA-injected mice compared with PBS controls 
(t test, **** = P < 0.0001). (G) Quantification reveals significantly fewer Ki67-positive hepatocytes in Ctnnb1-siRNA-injected mice compared 
with PBS-injected controls (Mann-Whitney U test, * = P < 0.05). (H) IHC staining reveals robust Ki67 staining of hepatocytes in PBS but 
not Ctnnb1-siRNA-injected animals. Cyclin D1 staining is significantly reduced in Ctnnb1-siRNA-injected mice, which also display a lack 
of hepatocyte-specific β-catenin staining (scale bar 50 µm). Abbreviation: d, day.
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on CDE diet (Fig. 6E). Staining for Ki67 displayed 
robust hepatocyte proliferation in PBS-injected controls 
but not Ctnnb1-siRNA-injected mice on CDE diet 
(Fig. 6H), which was confirmed by quantification 
(Fig. 6G). There was also a notable decrease in Cyclin 
D1 staining in the livers of Ctnnb1-siRNA-injected 
mice on CDE diet (Fig. 6H). Finally, IHC for β-catenin 
confirmed loss of β-catenin expression specifically in 
hepatocytes of Ctnnb1-siRNA-injected mice (Fig. 6H). 
Collectively, these results demonstrate that Ctnnb1-
siRNA-injected mice display increased liver injury and 
impairment of hepatocyte proliferation.
BeCs gIVe RIse to 
HepatoCytes IN Ctnnb1  
RNaI-tReateD MICe aFteR CDe 
DIet-INDuCeD lIVeR INJuRy
Having proved that injection of Ctnnb1-siRNA 
was sufficient to block hepatocyte proliferation in 
mice on CDE diet, we developed a mouse model 
of Krt19-CreERT+/--driven BEC lineage tracing(17) 
in combination with hepatocyte-specific Ctnnb1 
knockdown. To label BECs, tamoxifen was injected 
in Krt19-CreERT+/- mice during postnatal week 1, 
followed by a 2-week washout period to ensure 
elimination of any residual tamoxifen (Fig. 7A). 
Next, these mice were given weekly injections of 
Ctnnb1-siRNA throughout the course of CDE diet 
and recovery (Fig. 7A). In this model, BEC-derived 
hepatocytes can be directly traced because they 
will be tdTomato-positive (Fig. 7B). Prior to CDE 
diet administration, we verified that early postna-
tal tamoxifen administration labeled only BECs and 
not surrounding hepatocytes (Supporting Fig. S7A), 
implying that any tdTomato-positive hepatocytes 
would have to arise from a pre-existing tdToma-
to-positive BEC. We additionally determined the 
Krt19-CreERT+/- recombination efficiency in BECs 
in this model to be approximately 50% (Supporting 
Fig. S7B). After CDE diet and recovery, serum 
liver injury markers were approaching normal lev-
els in both PBS and Ctnnb1-siRNA-injected mice 
(Supporting Fig. S7B-D). Excitingly, clusters of 
tdTomato-positive hepatocytes that were also Hnf4α 
positive (Fig. 7C) and CYP2D6 positive (Fig. 8A) 
were evident in the Ctnnb1-siRNA-injected mice 
but not in the mice injected with PBS as a con-
trol. Quantification revealed that approximately 6% 
of hepatocytes were tdTomato positive in Ctnnb1-
siRNA-injected mice after CDE diet and recovery 
(Fig. 7D).
Immunofluorescence of β-catenin was strongly 
detected in the hepatocytes of PBS-injected mice 
but was significantly reduced in Ctnnb1-siRNA-
injected mice (Fig. 7E). Importantly, tdTomato- 
positive hepatocytes were located adjacent to clusters of 
β-catenin-positive BECs in Ctnnb1-siRNA-injected 
mice. Finally, clusters of tdTomato-positive hepato-
cytes in Ctnnb1-siRNA-injected mice would occa-
sionally extend all the way to the central vein, resulting 
in localized re-expression of β-catenin target GS 
(Fig. 8B). All together, these results demonstrate 
that BECs give rise to hepatocytes when hepatocyte 
proliferation is impaired, which was achieved in our 
model through the loss of β-catenin expression in 
hepatocytes in mice exposed to CDE diet–induced 
liver injury (Fig. 8C).
Discussion
The role of BECs in mediating LR has remained 
controversial, as several studies have reported a lim-
ited role for BEC differentiation to hepatocytes.(23-25) 
Recent studies have demonstrated that widespread 
hepatocyte senescence,(17) hepatocyte ablation,(20) 
impaired hepatocyte proliferation,(19) or prolonged 
exposure to severe liver injury(37) can trigger differ-
entiation of BECs to hepatocytes. Interestingly, a 
previous study reported ductular reaction and BEC-to-
hepatocyte differentiation in aged Albumin-Cre β-cat-
enin KO livers,(38) suggesting expression of β-catenin 
in hepatocytes is important for long-term liver health. 
Here, we demonstrate that hepatocyte-specific loss 
of β-catenin expression in combination with CDE 
diet–induced liver injury triggers severe impairment 
of hepatocyte proliferation and leads to unequivocal 
repopulation of liver with BEC-derived hepatocytes.
Genetic loss of β-catenin in hepatocytes led to 
extensive injury in the CDE diet model with robust 
expansion of BECs in both male and female mice (data 
not shown). Further, knockdown of Ctnnb1 expres-
sion in hepatocytes via siRNA also impaired hepato-
cyte proliferation after CDE diet. Intriguingly, BEC 
expansion occurred normally despite β-catenin loss in 
these cells in Albumin-Cre Ctnnb1 KO mice on CDE 
diet. However, the appearance of active-β-catenin in 
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FIg. 7. BEC-derived hepatocytes appear in Ctnnb1-siRNA but not PBS-treated mice following recovery period after CDE diet. 
(A) Krt19-CreERT+/- mice were given tamoxifen during postnatal week 1, followed by a 2-week washout. Mice were given subcutaneous 
injections of either Ctnnb1-siRNA or PBS 1 week prior to CDE diet as control, and injected weekly throughout the course of the 
experiment. Mice remained on CDE diet for 3 weeks followed by a 2-week recovery on normal diet. (B) After tamoxifen administration, 
BECs will be labeled with tdTomato, and Ctnnb1-siRNA injections induce hepatocyte-specific knockdown of Ctnnb1 expression. 
Therefore, a BEC-derived hepatocyte will be tdTomato positive and re-express β-catenin. (C) In control PBS-injected mice after CDE 
diet and recovery, BECs but not hepatocytes are tdTomato positive. In Ctnnb1-siRNA-injected mice, clusters of tdTomato-positive, 
Hnf4α-positive hepatocytes are evident, demonstrating BEC-to-hepatocyte conversion (scale bar 100 µm). (D) Quantification of 
tdTomato, Hnf4α double-positive cells reveals significantly more BEC-derived hepatocytes in Ctnnb1-siRNA-injected mice compared 
with PBS-injected controls (t test, * = P < 0.05). (E) In control PBS-injected mice, both BECs and hepatocytes are β-catenin positive, 
but only BECs are tdTomato positive. In Ctnnb1-siRNA-injected mice, hepatocytes lose cytoplasmic β-catenin-staining and clusters of 
tdTomato-positive hepatocytes (white arrows) are located periportally (scale bar 100 µm).
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KO2 mice, which retained β-catenin expression in 
BECs, suggests activation of β-catenin signaling in 
this compartment during CDE diet. This observation 
is in accordance with previous findings that activation 
of β-catenin in reactive BECs promotes differentia-
tion toward the hepatocyte lineage.(39) In our model, 
appearance of BEC-derived hepatocytes was evi-
dent as early as 3 days of recovery on basal diet after 
2 weeks of CDE diet, when cells positive for both BEC 
and hepatocyte markers could be observed. Excitingly, 
Hnf4α+/CK19+ cells have also been observed in a 
recent study demonstrating BEC-derived hepatocytes 
during long-term severe liver injury.(37) Our results 
suggest that differentiation of BECs to hepatocytes is 
limited or impaired during ongoing injury and that a 
period of recovery is necessary to allow BEC differen-
tiation to hepatocytes, as also shown elsewhere.(17,19,33)
Greater than 99% of hepatocytes were labeled with 
EYFP after AAV8-TBG-Cre injection, and after 
6 months of normal diet, the numbers of EYFP-
negative hepatocytes in both WT2 and KO2 mice 
were not significantly increased. Additionally, over 99% 
of hepatocytes were still EYFP positive in both WT2 
and KO2 mice after 2 weeks of CDE diet, suggesting 
no significant population of hepatocytes escaping ini-
tial Cre-recombination, as these cells would express 
FIg. 8. BEC-derived hepatocytes express mature hepatocyte markers. (A) BEC-derived tdTomato-positive hepatocytes are positive 
for hepatocyte marker CYP2D6 in Ctnnb1-siRNA-injected mice (scale bar 100 µm). (B) BEC-derived tdTomato-positive hepatocytes 
in Ctnnb1-siRNA-injected mice extend all the way to the central vein, resulting in re-expression of β-catenin-target GS (scale bar 100 
µm). (C) Schematic illustrating key findings: When hepatocyte proliferation is intact (β-catenin WT hepatocytes) after CDE diet–
induced liver injury, liver regeneration is driven by hepatocyte proliferation. When mice with hepatocyte-specific loss of β-catenin are 
subjected to CDE diet, BEC-to-hepatocyte differentiation occurs to facilitate liver regeneration.
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β-catenin and would be expected to have a prolifera-
tive advantage during CDE diet–induced liver injury. 
In this negative tracing model, we found that after 
recovery, approximately 20% of periportal hepatocytes 
were BEC derived. Interestingly, in our positive lin-
eage tracing model, we found only 6% of hepatocytes 
were BEC derived. This is attributable to the fact 
that initially only around 50% of BECs were labeled 
with tdTomato in this model, suggesting potentially 
12% of hepatocytes were BEC derived in our model 
after factoring in the limited recombination efficiency. 
Furthermore, newly BEC-derived hepatocytes may 
be susceptible to siRNA-mediated Ctnnb1 knock-
down, potentially reducing their proliferation during 
recovery from CDE diet, further reducing tdTomato- 
positive hepatocyte numbers.
Although our data convincingly prove the differ-
entiation and long-term survival of BEC-derived 
hepatocytes, much remains to be elucidated about 
both the long-term effects of BEC-derived hepato-
cytes on liver health and the mechanisms underly-
ing BEC-to-hepatocyte differentiation. For instance, 
it will be interesting to determine if BEC-derived 
hepatocytes are equally as adept at promoting res-
olution of liver injury, such as resolution of fibrosis. 
Additionally, although factors that promote ductular 
reaction are better known,(40) our knowledge of the 
factors promoting BEC differentiation to hepatocytes 
is much more limited. Because our model establishes a 
clear timeline for BEC differentiation to hepatocytes, 
it will be invaluable in determining the factors that 
underlie this process. For example, as we have demon-
strated the importance of β-catenin signaling in LR, 
this would potentially allow promotion of BEC-to-
hepatocyte differentiation while circumventing acti-
vation of oncogenic β-catenin signaling in patients. 
Additionally, it will be important to determine the 
threshold of hepatic impairment that triggers BEC-
to-hepatocyte differentiation, as this may lead to the 
development of biomarkers for patients with severe 
liver disease that are amenable to such treatments. 
These would be important steps in developing regen-
erative medicine therapies for the treatment of chronic 
liver disease.
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